Prof. Frank Leebeek: About 20 % of People with Von Willebrand’s Disease Have Something Strange Going On
Erasmus MC shared a post on LinkedIn:
“Scientists at Erasmus MC have discovered that Von Willebrand’s blood clotting disease is not always caused by an error in the gene of the same name. A problem in the secretion of the clotting protein can also trigger the disease, they showed.
In people with Von Willebrand disease, something goes wrong in blood clotting. This is usually because their body produces too little or a poorly functioning version of the clotting protein Von Willebrand factor. That protein acts as a kind of band-aid to stop bleeding.
About twenty percent of people with Von Willebrand’s disease have something strange going on. They do not have an error in the Von Willebrand factor gene, but they do have too little clotting protein in their blood. “We have been looking for years to find out what causes the disease in these people,” says hematologist Prof. Frank Leebeek of Erasmus MC. A recent study by the Department of Hematology, published in Blood, points to a new cause.”
Read full paper here.
Stay updated with Hemostasis Today.
-
Oct 31, 2025, 14:17When Stories Save Lives: Reza Shojaei Shares Blood and Plasma Pulse Newest Issue
-
Oct 31, 2025, 13:34Charlotte Pilling Invites You to ''Women in Hematology'' US Focus Meeting
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
-
Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
-
Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
-
Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
-
Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 31, 2025, 14:41Emilya Huseynova Reflects on AABB 2025
-
Oct 31, 2025, 14:33Cihan Ay Delivers Seminar at McMaster University on Thrombosis Research
-
Oct 31, 2025, 14:25Thomas Reiser Steps Down as ISTH Executive Director After 14+ Years of Leadership
-
Oct 31, 2025, 14:02Murray Adams Reflects on His Week Attending Blood 2025
-
Oct 31, 2025, 13:10Angelique Balguid: World Stroke Day is More Than a Moment — It’s a Movement